BNP Paribas Financial Markets’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,851
| Closed | -$259K | – | 3753 |
|
|
2018
Q4 | $259K | Sell |
1,851
-1,060
| -36% | -$148K | ﹤0.01% | 1391 |
|
|
2018
Q3 | $497K | Buy |
2,911
+869
| +43% | +$148K | ﹤0.01% | 1445 |
|
|
2018
Q2 | $354K | Sell |
2,042
-2,822
| -58% | -$490K | ﹤0.01% | 1577 |
|
|
2018
Q1 | $561K | Buy |
4,864
+77
| +2% | +$8.88K | ﹤0.01% | 1628 |
|
|
2017
Q4 | $403K | Buy |
4,787
+2,289
| +92% | +$193K | ﹤0.01% | 1979 |
|
|
2017
Q3 | $230K | Buy |
2,498
+254
| +11% | +$23.4K | ﹤0.01% | 2098 |
|
|
2017
Q2 | $180K | Buy |
2,244
+2,194
| +4,388% | +$176K | ﹤0.01% | 2151 |
|
|
2017
Q1 | $2.1K | Sell |
50
-694
| -93% | -$29.2K | ﹤0.01% | 2967 |
|
|
2016
Q4 | $23.9K | Sell |
744
-197
| -21% | -$6.33K | ﹤0.01% | 2619 |
|
|
2016
Q3 | $24.6K | Buy |
941
+387
| +70% | +$10.1K | ﹤0.01% | 2777 |
|
|
2016
Q2 | $12.8K | Buy |
+554
| New | +$12.8K | ﹤0.01% | 2778 |
|
|
2016
Q1 | – | Sell |
-1,732
| Closed | -$49.3K | – | 3343 |
|
|
2015
Q4 | $49.3K | Buy |
1,732
+65
| +4% | +$1.85K | ﹤0.01% | 2820 |
|
|
2015
Q3 | $29.1K | Buy |
1,667
+1,019
| +157% | +$17.8K | ﹤0.01% | 3176 |
|
|
2015
Q2 | $11.7K | Buy |
648
+571
| +742% | +$10.3K | ﹤0.01% | 3298 |
|
|
2015
Q1 | $959 | Buy |
+77
| New | +$959 | ﹤0.01% | 3557 |
|